Table 3 Incidence rates of End Stage Kidney Failure per 10,000 person years (95% CI) in the QResearch derivation cohort and THIN validation cohort
QResearch derivation cohort | THIN validation cohort | ||
|---|---|---|---|
Women | total | 3.03 (2.87 to 3.20) | 3.03 (2.86 to 3.21) |
35-39 yrs | 0.83 (0.65 to 1.07) | 0.70 (0.52 to 0.93) | |
40-44 yrs | 0.95 (0.74 to 1.22) | 1.18 (0.93 to 1.49) | |
45-49 yrs | 1.40 (1.12 to 1.74) | 1.41 (1.13 to 1.78) | |
50-54 yrs | 1.64 (1.33 to 2.02) | 1.95 (1.61 to 2.38) | |
55-59 yrs | 2.56 (2.17 to 3.02) | 2.99 (2.55 to 3.50) | |
60-64 yrs | 4.45 (3.86 to 5.13) | 4.29 (3.69 to 4.98) | |
65-69 yrs | 6.44 (5.68 to 7.30) | 7.00 (6.18 to 7.93) | |
70-74 yrs | 11.6 (10.52 to 12.79) | 9.59 (8.58 to 10.72) | |
Men | Total | 3.66 (3.48 to 3.85) | 3.88 (3.69 to 4.08) |
35-39 yrs | 1.01 (0.80 to 1.26) | 1.19 (0.95 to 1.48) | |
40-44 yrs | 1.18 (0.95 to 1.47) | 1.55 (1.27 to 1.89) | |
45-49 yrs | 1.51 (1.22 to 1.86) | 1.98 (1.64 to 2.39) | |
50-54 yrs | 2.30 (1.94 to 2.73) | 2.38 (2.00 to 2.84) | |
55-59 yrs | 3.64 (3.17 to 4.18) | 3.58 (3.10 to 4.14) | |
60-64 yrs | 5.09 (4.44 to 5.82) | 5.22 (4.55 to 5.99) | |
65-69 yrs | 9.48 (8.52 to 10.55) | 9.71 (8.70 to 10.83) | |
70-74 yrs | 14.24 (12.93 to 15.68) | 14.36 (12.98 to 15.88) |